243 related articles for article (PubMed ID: 29059151)
1. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.
Abbaci A; Talbot H; Saada S; Gachard N; Abraham J; Jaccard A; Bordessoule D; Fauchais AL; Naves T; Jauberteau MO
Oncogene; 2018 Feb; 37(6):756-767. PubMed ID: 29059151
[TBL] [Abstract][Full Text] [Related]
2. BDNF belongs to the nurse-like cell secretome and supports survival of B chronic lymphocytic leukemia cells.
Talbot H; Saada S; Barthout E; Gallet PF; Gachard N; Abraham J; Jaccard A; Troutaud D; Lalloué F; Naves T; Fauchais AL; Jauberteau MO
Sci Rep; 2020 Jul; 10(1):12572. PubMed ID: 32724091
[TBL] [Abstract][Full Text] [Related]
3. Targeting the NTSR2/TrkB oncogenic pathway in chronic lymphocytic leukemia.
Ikhlef L; Yassine M; Chandouri B; Rivière L; Naves T; Dmytruk N; Gachard N; Jauberteau MO; Gallet PF
Sci Rep; 2024 Mar; 14(1):6084. PubMed ID: 38480783
[TBL] [Abstract][Full Text] [Related]
4. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of neurotensin and specific receptors, NTSR1 and NTSR2, in normal and malignant human B lymphocytes.
Saada S; Marget P; Fauchais AL; Lise MC; Chemin G; Sindou P; Martel C; Delpy L; Vidal E; Jaccard A; Troutaud D; Lalloué F; Jauberteau MO
J Immunol; 2012 Dec; 189(11):5293-303. PubMed ID: 23109725
[TBL] [Abstract][Full Text] [Related]
6. The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1.
Ayala-Sarmiento AE; Martinez-Fong D; Segovia J
Cell Mol Neurobiol; 2015 Aug; 35(6):785-95. PubMed ID: 25772140
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation.
Azoulay D; Herishanu Y; Shapiro M; Brandshaft Y; Suriu C; Akria L; Braester A
Exp Hematol; 2018 Jul; 63():17-21.e1. PubMed ID: 29705266
[TBL] [Abstract][Full Text] [Related]
8. The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.
Baudot AD; Jeandel PY; Mouska X; Maurer U; Tartare-Deckert S; Raynaud SD; Cassuto JP; Ticchioni M; Deckert M
Oncogene; 2009 Sep; 28(37):3261-73. PubMed ID: 19581935
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
10. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
Yuan Y; Ye HQ; Ren QC
Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth.
Kawamura N; Kawamura K; Manabe M; Tanaka T
Endocrinology; 2010 Jul; 151(7):3006-14. PubMed ID: 20463055
[TBL] [Abstract][Full Text] [Related]
12. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
13. Differential control of G0 programme in chronic lymphocytic leukaemia: a novel prognostic factor.
Danilov AV; Klein AK; Lee HJ; Baez DV; Huber BT
Br J Haematol; 2005 Feb; 128(4):472-81. PubMed ID: 15686454
[TBL] [Abstract][Full Text] [Related]
14. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.
Lee YK; Bone ND; Strege AK; Shanafelt TD; Jelinek DF; Kay NE
Blood; 2004 Aug; 104(3):788-94. PubMed ID: 14996703
[TBL] [Abstract][Full Text] [Related]
15. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
Lee J; Jiffar T; Kupferman ME
PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of long noncoding antisense RNA brain-derived neurotrophic factor attenuates hypoxia/reoxygenation-induced nerve cell apoptosis through the BDNF-TrkB-PI3K/Akt signaling pathway.
Zhong JB; Li X; Zhong SM; Liu JD; Chen CB; Wu XY
Neuroreport; 2017 Sep; 28(14):910-916. PubMed ID: 28777258
[TBL] [Abstract][Full Text] [Related]
17. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance.
Lee YK; Shanafelt TD; Bone ND; Strege AK; Jelinek DF; Kay NE
Leukemia; 2005 Apr; 19(4):513-23. PubMed ID: 15703780
[TBL] [Abstract][Full Text] [Related]
18. TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease.
Kang SS; Zhang Z; Liu X; Manfredsson FP; Benskey MJ; Cao X; Xu J; Sun YE; Ye K
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10773-10778. PubMed ID: 28923922
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hydatidiform molar growth by inhibiting endogenous brain-derived neurotrophic factor/tyrosine kinase B signaling.
Kawamura K; Kawamura N; Kawagoe Y; Kumagai J; Fujimoto T; Terada Y
Endocrinology; 2012 Aug; 153(8):3972-81. PubMed ID: 22719055
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
Tsai YF; Tseng LM; Hsu CY; Yang MH; Chiu JH; Shyr YM
PLoS One; 2017; 12(6):e0178173. PubMed ID: 28604807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
